Hepatitis C Committee

Chair: Dr. P. Kishore, MD, MPH, CMA

(Boston NAMA)

Committee Members

Paul Bowman, CMA 

Cheri Jarvis, CMA 


The HCV Committee was created to empower methadone patients through education and advocacy and to provide support for those that do test positive for Hepatitis C.


What Is Hepatitis C?

  • Hepatitis is an inflammation of the liver. Although in many people the diseased liver is able to repair itself and regain function, it may progress to scarring of the liver and chronic liver disease. Hepatitis can have numerous causes. A common cause is infection with one of the several types of viruses (e.g., hepatitis A, B, or C viruses).
  • Hepatitis C virus (HCV) infection occurs when blood, or other body fluids from an infected person enters the body of an uninfected person. In 2000, about 30,000 new infections occurred. Most of these infections occurred among young adults 20-39 years old. Injection drug use and blood transfusion prior to 1992 are major risk factor for HCV infection. About 3.9 million American have been infected with HCV and 2.7 million have chronic infection. In 2000, about 30,000 new infections occurred. Most of these infections occurred among young adults 20-39 years old.
  • HCV infection is becoming a leading cause of cirrhosis. In addition to genetic factors in the infected person three independent factors are associated with an increased rate of disease progression. These factors include daily alcohol consumption, age at infection of more than 40 years, and male gender. These factors have a greater influence on progression to cirrhosis in HCV infection than the virus itself.

What Should You Do If You Have Hepatitis C?

  • There are several actions all people who have chronic viral hepatitis C should take as general measures. Most important of all is to not drink alcoholic beverages, and if necessary, get into treatment, because alcohol makes liver disease worse. Injection drug users should stop injecting drugs and get into and stay in substance abuse treatment. All individuals with chronic liver disease should be immunized against hepatitis A. Individuals with chronic HCV who are at risk also should be immunized against hepatitis B.

Surviving Hep C Group

This group is a support group with emphasis on Hepatitis C. Everyone is welcome to share their experience’s and stories in this group no matter what your status might be. Everyone is encouraged to share information and educational topics. Hepatitis C can be survived, but we have to empower ourselves with knowlege and be our own treatment advocates.

Come on and join NAMA’s hepatitis group and talk with others who have HCV.

http://groups.yahoo.com/group/SurvivingHepC/

Contact List Manager Cheri Jarvis, CMA

[email protected]


Important Documents


Info Facts


Info Facts are prepared by the HCV Committee and under the direction of Dr. Kishore.

Publications


Similar Posts

  • Affordable Care Act

    Admin 08/28/2021

    Resources  Equal Parity On March 23, 2010, President Obama signed the Affordable Care Act (ACA) into law. This puts in place comprehensive health insurance reforms that will roll out over four years and beyond. Health reform includes several key steps in the next 4 years. Medicaid will be expanded to allow more people at the lowest…

  • Category: In Memoriam

    Admin 02/20/2023

    Paul Edward Bowman (1963-2021) December 3, 2021 NAMA Recovery is saddened to report the passing of a long-standing member of our Board of Directors. Paul Edward Bowman, Jr, 58, passed away on November 22, 2021. Paul was born in Boston, MA and lived most of his life in Quincy, MA. Paul served Massachusetts residents for…

  • Tag: nursing

    Admin 05/11/2021

    Justice Department Finds that Indiana State Nursing Board Discriminates Against People with Opioid Use Disorder March 30, 2022 FOR IMMEDIATE RELEASE Friday, March 25, 2022 Indianapolis – Today, the Justice Department found that the Indiana State Board of Nursing (Nursing Board) violated the Americans with Disabilities Act (Ada) by prohibiting nurses who take medication to…

  • |

    Buprenorphine Information for Physicians

    Admin 05/07/2023

    Federal Law Basic Information About DATA On October 17, 2000 Title XXXV of the Children’s Health Act of 2000 was enacted that permits the prescribing of schedule III, IV or V opioid treatment drugs that are approved by the FDA for maintenance or detoxification treatment. Read the full text: Public Law 106-310, Sec. 3502. Controlled…

  • Hot Topic Roundtable

    Admin 04/19/2023

    National Methadone Conference AMTA 2001 Tuesday, October 9th 2 P.M. Administrative Detox: Necessary Use or Abuse Joe Neuberger, Delaware NAMA James DePasquale, Long Beach Patient Committee This roundtable examined the practice of “administrative detoxification” from programs, and explored the conflicts between what programs often perceive as a necessary evil and patients often perceive as a…

  • The National Methadone Conference

    Admin 01/22/2022

    American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Pre Conference Session 8:30 AM – 5:45 PM April 12, 2003 Sharon Dow, MS Joint Commission Washington, DC Joanne Page, MSW Council On Accreditation New York, NY Walter Ginter NAMA Westport, CT J. Thomas Payte, MD Drug Dependence Associates San Antonio,…